---
figid: PMC9372505__fonc-12-910505-g007
figtitle: Concurrent inhibition of FAK/SRC and MEK overcomes MEK inhibitor resistance
  in Neurofibromatosis Type I related malignant peripheral nerve sheath tumors
organisms:
- Homo sapiens
- Mus musculus
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC9372505
filename: fonc-12-910505-g007.jpg
figlink: /pmc/articles/PMC9372505/figure/f7/
number: F7
caption: Schematic of the study. LAMA4 induced MEKi resistance in MPNSTs by upregulating
  integrin b1/FAK/SRC pathway and subsequently reactivating MAPK signaling.
papertitle: Concurrent inhibition of FAK/SRC and MEK overcomes MEK inhibitor resistance
  in Neurofibromatosis Type I related malignant peripheral nerve sheath tumors.
reftext: Yihui Gu, et al. Front Oncol. 2022;12:910505.
year: '2022'
doi: 10.3389/fonc.2022.910505
journal_title: Frontiers in Oncology
journal_nlm_ta: Front Oncol
publisher_name: Frontiers Media S.A.
keywords: neurofibromatosis type I | MPNST | MEK | drug resistance | integrins | FAK
  (focal adhesion kinase)
automl_pathway: 0.9520585
figid_alias: PMC9372505__F7
figtype: Figure
redirect_from: /figures/PMC9372505__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9372505__fonc-12-910505-g007.html
  '@type': Dataset
  description: Schematic of the study. LAMA4 induced MEKi resistance in MPNSTs by
    upregulating integrin b1/FAK/SRC pathway and subsequently reactivating MAPK signaling.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Mdk
  - ras
  - Hras
  - Kras
  - Rem1
  - Zhx2
  - Ephb2
  - Mapk1
  - Ptk2
  - Src
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - EPHB2
  - MAPK1
  - MAPK3
  - MTG1
  - PTK2
  - SRC
  - FGR
  - FYN
  - YES1
  - Dsor1
  - Mtk
  - Ras64B
  - Ras85D
  - Raf
  - scb
  - Erk7
  - rl
  - LanB1
  - LanA
  - LanB2
  - Fak
  - Src42A
  - Csk
  - Src64B
---
